Brief Overview of a Decade of Genome-Wide Association Studies on Primary Hypertension

الملخص EN

Primary hypertension is widely believed to be a complex polygenic disorder with the manifestation influenced by the interactions of genomic and environmental factors making identification of susceptibility genes a major challenge.

With major advancement in high-throughput genotyping technology, genome-wide association study (GWAS) has become a powerful tool for researchers studying genetically complex diseases.

GWASs work through revealing links between DNA sequence variation and a disease or trait with biomedical importance.

The human genome is a very long DNA sequence which consists of billions of nucleotides arranged in a unique way.

A single base-pair change in the DNA sequence is known as a single nucleotide polymorphism (SNP).

With the help of modern genotyping techniques such as chip-based genotyping arrays, thousands of SNPs can be genotyped easily.

Large-scale GWASs, in which more than half a million of common SNPs are genotyped and analyzed for disease association in hundreds of thousands of cases and controls, have been broadly successful in identifying SNPs associated with heart diseases, diabetes, autoimmune diseases, and psychiatric disorders.

It is however still debatable whether GWAS is the best approach for hypertension.

The following is a brief overview on the outcomes of a decade of GWASs on primary hypertension.